Clever Leaves Holdings (Clever Leaves Holdings) Cash And Cash Equivalents : $6.83 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Clever Leaves Holdings Cash And Cash Equivalents?

Clever Leaves Holdings's quarterly cash and cash equivalents increased from Jun. 2023 ($5.08 Mil) to Sep. 2023 ($6.47 Mil) and increased from Sep. 2023 ($6.47 Mil) to Dec. 2023 ($6.83 Mil).

Clever Leaves Holdings's annual cash and cash equivalents declined from Dec. 2021 ($37.23 Mil) to Dec. 2022 ($12.45 Mil) and declined from Dec. 2022 ($12.45 Mil) to Dec. 2023 ($6.83 Mil).

Clever Leaves Holdings Cash And Cash Equivalents Historical Data

The historical data trend for Clever Leaves Holdings's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clever Leaves Holdings Cash And Cash Equivalents Chart

Clever Leaves Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

12.04

79.11

37.23

12.45

6.83

Clever Leaves Holdings Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial												12.45	6.36	5.08	6.47	6.83

Clever Leaves Holdings Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Clever Leaves Holdings (OTCPK:CLVRW) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Clever Leaves Holdings Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Clever Leaves Holdings's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Clever Leaves Holdings (Clever Leaves Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Clever Leaves Holdings Inc (OTCPK:CLVRW) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

CLVR:USA

Address

19-B Parque Industrial Tibitoc, Tocancipá, Cundinamarca, Bodega, Colombia, BC, CAN

Website

https://www.cleverleaves.com

Clever Leaves Holdings Inc is a producer of pharmaceutical and consumer cannabis brands. The company operates and has investments in Canada, Colombia, Germany, Portugal, and the United States. The company operates in two reportable segments, 1. The Cannabinoid operating segment: is comprised of the Company's cultivation, extraction, and commercialization of cannabinoid products. 2. Non-Cannabinoid operating segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements.